| Authors: |
Werner R; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany., Haug A; Clinical Department of Nuclear Medicine, University Hospital AKH Vienna, Wien, Austria., Buske C; Institute of Experimental Cancer Research, Ulm University Hospital, Ulm, Germany., Heidegger S; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany., Illert AL; Department of Hematology and Oncology, Freiburg University Hospital, Freiburg, Germany., Bassermann F; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany., Herhaus P; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany., Buck A; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany., Duell J; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Topp MS; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Kraus S; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Einsele H; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Lapa C; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Raderer M; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Lenz G; Department of Medicine A - Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Habringer S; Department of Hematology, Oncology and Cancer Immunology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charite Universitatsmedizin Berlin, Berlin, Germany., von Tresckow B; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany., Keller U; Department of Hematology, Oncology and Cancer Immunology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charite Universitatsmedizin Berlin, Berlin, Germany. |
